about
Airway, but not serum or urinary, levels of YKL-40 reflect inflammation in early cystic fibrosis lung disease.Obesity, diabetes and atrial fibrillation; epidemiology, mechanisms and interventions.Diabetes, Obesity and Atrial Fibrillation: Epidemiology, Mechanisms and InterventionsExtracellular matrix markers and risk of myocardial infarction: The HUNT Study in Norway.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
YKL-40: a new biomarker in cardiovascular disease?
@en
YKL-40: a new biomarker in cardiovascular disease?
@nl
type
label
YKL-40: a new biomarker in cardiovascular disease?
@en
YKL-40: a new biomarker in cardiovascular disease?
@nl
prefLabel
YKL-40: a new biomarker in cardiovascular disease?
@en
YKL-40: a new biomarker in cardiovascular disease?
@nl
P2093
P2860
P356
P1476
YKL-40: a new biomarker in cardiovascular disease?
@en
P2093
Anders Bruun Mathiasen
Jens Kastrup
Kristoffer Mads Aaris Henningsen
Marina Jurjevna Harutyunyan
Naja Dam Mygind
P2860
P304
P356
10.2217/BMM.10.58
P577
2010-08-01T00:00:00Z